Clinical Trials Insight: 700025089
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2007
At a glance
- Drugs Caplacizumab (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Ablynx
- 17 Dec 2007 Positive results have been reported in a Ablynx media release.
- 17 Dec 2007 Status changed from in progress to completed.
- 20 Jul 2007 New trial record.